Salipada, Badria A.
HRN: 23-95-43 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/08/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/08/2023
11/14/2023
IVTT
600mg
Q6
Infected Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes